T 1134/21 of 25.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T113421.20240625
- Date of decision
- 25 June 2024
- Case number
- T 1134/21
- Petition for review of
- -
- Application number
- 11736812.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Anti-DLL3 antibody
- Applicant name
- Chugai Seiyaku Kabushiki Kaisha
The University of Tokyo - Opponent name
- Boehringer Ingelheim RCV GmbH & Co KG /
Boehringer Ingelheim International GmbH
Schiweck Weinzierl Koch Patentanwälte
Partnerschaft mbB
AbbVie Inc. - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.